Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
$610.9m
reported value
-12.6% vs Q1 2026
126positions
39.5%in top 10
27 new
18 added
29 reduced
28 sold out
vs Q1 2026
Options: 13 call positions ($130.8m notional), 17 put positions ($186.5m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ABIVAX SA ABVX | $43.4m7.10% | Added +271.0k |
| KODIAK SCIENCES INC KOD | $41.3m6.76% | Reduced -206.1k |
| ALUMIS INC ALMS | $24.5m4.01% | Reduced -343.0k |
| PRAXIS PRECISION MEDICINES I PRAX | $24.4m3.99% | Added +1.3k |
| VAXCYTE INC PCVX | $22.6m3.70% | Reduced -40.0k |
| ANI PHARMACEUTICALS INC ANIP | $22.5m3.69% | Added +125.0k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $17.8m2.91% | Added +17.3k |
| ARCUS BIOSCIENCES INC RCUS | $15.6m2.55% | New |
| RELMADA THERAPEUTICS INC RLMD | $14.9m2.43% | Reduced -540.0k |
| CAPRICOR THERAPEUTICS INC CAPR | $14.5m2.38% | Added +76.2k |
| COGENT BIOSCIENCES INC COGT | $14.3m2.34% | New |
| VERA THERAPEUTICS INC VERA | $13.3m2.18% | Added +110.0k |
| CONTINEUM THERAPEUTICS INC CTNM | $13.2m2.17% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $11.5m1.88% | Reduced -230.0k |
| C4 THERAPEUTICS INC CCCC | $11.4m1.86% | New |
| MAZE THERAPEUTICS INC MAZE | $11.3m1.85% | Unchanged |
| BIOHAVEN LTD BHVN | $11.1m1.82% | Added +335.7k |
| CONNECT BIOPHARMA HLDGS LTD CNTB | $10.8m1.77% | Reduced -850.0k |
| ALTO NEUROSCIENCE INC ANRO | $10.7m1.76% | Reduced -107.7k |
| PHARVARIS N V PHVS | $10.7m1.75% | Reduced -178.0k |
| JADE BIOSCIENCES INC JBIO | $9.5m1.55% | Reduced -85.0k |
| DAMORA THERAPEUTICS INC COM NEW | $8.7m1.43% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $7.8m1.28% | New |
| PELTHOS THERAPEUTICS INC PTHS | $7.3m1.19% | Unchanged |
| ZURA BIO LTD ZURA | $7.2m1.18% | Added +25.0k |
| TECTONIC THERAPEUTIC INC TECX | $7.1m1.16% | Added +48.3k |
| SPRUCE BIOSCIENCES INC SPRB | $6.6m1.07% | Unchanged |
| HIMS & HERS HEALTH INC HIMS | $6.5m1.07% | New |
| ENLIVEN THERAPEUTICS INC ELVN | $6.4m1.05% | New |
| PROQR THRAPEUTICS N V PRQR | $6.4m1.04% | Added +1.9m |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $6.2m1.02% | Reduced -77.7k |
| OVID THERAPEUTICS INC OVID | $6.1m1.00% | Reduced -625.0k |
| OCUGEN INC OCGN | $6.1m0.99% | Unchanged |
| ALPHA COGNITION INC ACOG | $6.0m0.99% | Reduced -220.0k |
| HARROW INC HROW | $5.8m0.94% | Reduced -407.3k |
| KAZIA THERAPEUTICS LTD KZIA | $5.6m0.91% | New |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $5.5m0.91% | Reduced -317.0k |
| Q32 BIO INC QTTB | $5.5m0.90% | New |
| EUPRAXIA PHARMACEUTICALS INC EPRX | $5.4m0.88% | Reduced -405.0k |
| BIOAGE LABS INC BIOA | $4.9m0.80% | New |
| REZOLUTE INC RZLT | $4.9m0.80% | Added +918.5k |
| OLEMA PHARMACEUTICALS INC OLMA | $4.8m0.78% | Reduced -215.0k |
| MONOPAR THERAPEUTICS INC MNPR | $4.4m0.73% | New |
| BRIDGEBIO PHARMA INC BBIO | $4.3m0.70% | Reduced -102.7k |
| INVENTIVA SA IVA | $4.2m0.68% | Reduced -300.0k |
| ABSCI CORPORATION ABSI | $4.1m0.67% | New |
| ALECTOR INC ALEC | $4.0m0.65% | Reduced -100.0k |
| CLIMB BIO INC CLYM | $3.9m0.64% | New |
| FULCRUM THERAPEUTICS INC FULC | $3.8m0.63% | Unchanged |
| CARDIOL THERAPEUTICS INC CRDL | $3.5m0.58% | Added +600.0k |
| CUE BIOPHARMA INC CUE | $3.3m0.54% | New |
| CUMBERLAND PHARMACEUTICALS I CPIX | $3.3m0.53% | Reduced -50.0k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $3.1m0.51% | New |
| REIN THERAPEUTICS INC RNTX | $3.1m0.50% | New |
| ARVINAS INC ARVN | $3.0m0.49% | Unchanged |
| ACUMEN PHARMACEUTICALS INC ABOS | $2.8m0.46% | Unchanged |
| PROMIS NEUROSCIENCES INC PMN | $2.7m0.44% | Added +150.0k |
| ANNEXON INC ANNX | $2.5m0.40% | Reduced -150.0k |
| LEXEO THERAPEUTICS INC LXEO | $2.4m0.39% | Unchanged |
| DELCATH SYS INC DCTH | $2.3m0.38% | Reduced -245.6k |
| INVIVYD INC IVVD | $2.3m0.38% | Unchanged |
| CABALETTA BIO INC CABA | $2.2m0.36% | Reduced -200.0k |
| NEUMORA THERAPEUTICS INC. NMRA | $2.2m0.36% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $2.1m0.35% | New |
| TARSUS PHARMACEUTICALS INC TARS | $2.0m0.32% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $1.8m0.30% | Reduced -35.0k |
| JOURNEY MED CORP DERM | $1.8m0.29% | Unchanged |
| DBV TECHNOLOGIES S A DBVT | $1.7m0.28% | Unchanged |
| IBIO INC IBIO | $1.7m0.27% | Unchanged |
| AVALO THERAPEUTICS INC AVTX | $1.7m0.27% | New |
| ANTERIS TECHNOLOGIES GLOBAL AVR | $1.6m0.27% | Reduced -200.0k |
| PALISADE BIO INC PALI | $1.6m0.26% | Added +475.0k |
| AMANAT ACQUISITION CORP AMAN | $1.5m0.25% | New |
| KALARIS THERAPEUTICS INC KLRS | $1.5m0.24% | Unchanged |
| QUINCE THERAPEUTICS INC IRLA | $1.3m0.22% | New |
| LIPOCINE INC NEW LPCN | $1.3m0.21% | Unchanged |
| IMMUNOME INC IMNM | $1.3m0.21% | New |
| PLIANT THERAPEUTICS INC PLRX | $1.1m0.19% | New |
| IMMUNIC INC IMUX | $1.0m0.17% | New |
| QUOIN PHARMACEUTICALS LTD QNRX | $1.0m0.17% | Unchanged |
| EQUILLIUM INC EQ | $971.4k0.16% | Unchanged |
| NEURONETICS INC STIM | $911.5k0.15% | Unchanged |
| FAETH THERAPEUTICS INC FTH | $884.6k0.14% | Added +29.0k |
| FRACTYL HEALTH INC COM | $873.8k0.14% | Unchanged |
| CYBIN INC COM NEW | $873.5k0.14% | Unchanged |
| FIRST TRACKS BIOTHERAPEUTICS TRAX | $860.6k0.14% | New |
| VERASTEM INC VSTM | $817.0k0.13% | Unchanged |
| DIREXION SHS ETF TR LABD | $815.9k0.13% | Unchanged |
| PEPGEN INC PEPG | $804.9k0.13% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $710.9k0.12% | Unchanged |
| CNS PHARMACEUTICALS INC CNSP | $649.3k0.11% | Added +90.0k |
| LYELL IMMUNOPHARMA INC LYEL | $577.2k0.09% | Unchanged |
| WAVE LIFE SCIENCES LTD 96663EUR | $495.5k0.08% | Unchanged |
| IMMATICS N.V IMTX | $492.0k0.08% | Unchanged |
| PASSAGE BIO INC PASG | $485.6k0.08% | Added +31.4k |
| NEXTCURE INC NXTC | $461.3k0.08% | Added +50.0k |
| FORTE BIOSCIENCES INC FBRX | $445.7k0.07% | Reduced -98.0k |
| SOLID BIOSCIENCES INC SLDB | $429.1k0.07% | Reduced -221.5k |
| TRAWS PHARMA INC TRAW | $403.2k0.07% | Reduced -200.0k |
| LEXICON PHARMACEUTICALS INC LXRX | $395.2k0.06% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| TERNS PHARMACEUTICALS INC | $76.8m1.5m shares |
| CYTOKINETICS INC CYTK | $18.7m283.6k shares |
| REVOLUTION MEDICINES INC RVMD | $15.9m163.1k shares |
| ORUKA THERAPEUTICS INC ORKA | $11.9m242.0k shares |
| SOLENO THERAPEUTICS INC SLNO | $11.5m344.1k shares |
| IONIS PHARMACEUTICALS INC IONS | $9.5m127.0k shares |
| PALVELLA THERAPEUTICS INC NE PVLA | $8.1m64.6k shares |
| ELI LILLY & CO LLY | $6.0m6.5k shares |
| SURROZEN INC SRZN | $5.0m173.1k shares |
| LEGEND BIOTECH CORP LEGN | $4.1m226.9k shares |
| KARYOPHARM THERAPEUTICS INC KPTI | $4.1m733.4k shares |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $2.6m241.0k shares |
| VIR BIOTECHNOLOGY INC VIR | $2.6m293.3k shares |
| BRIDGEBIO ONCOLOGY THERAPEUT BBOT | $2.4m270.2k shares |
| NUVALENT INC | $2.4m23.6k shares |
| JAZZ PHARMACEUTICALS PLC JAZZ | $2.4m12.5k shares |
| UNIQURE NV QURE | $1.5m91.1k shares |
| DEFINIUM THERAPEUTICS INC DFTX | $1.1m58.8k shares |
| KEZAR LIFE SCIENCES INC KZR | $758.4k102.2k shares |
| IMMUNIC INC | $748.9k674.7k shares |
| CENTESSA PHARMACEUTICALS PLC | $719.4k18.1k shares |
| KALVISTA PHARMACEUTICALS INC KALV | $706.9k35.1k shares |
| INSMED INC INSM | $689.1k4.2k shares |
| SANGAMO THERAPEUTICS INC SGMOQ | $300.9k1.2m shares |
| VERU INC VERU | $295.1k133.5k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $47.5m300.0k shares | Reduced |
| ABIVAX SA ABVX · Call | $45.5m341.1k shares | Added |
| ABIVAX SA ABVX · Put | $33.3m250.0k shares | New |
| IONIS PHARMACEUTICALS INC IONS · Call | $31.7m400.0k shares | Added |
| MODERNA INC MRNA · Put | $28.0m400.0k shares | New |
| IONIS PHARMACEUTICALS INC IONS · Put | $23.8m300.0k shares | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS · Put | $13.6m400.0k shares | New |
| ALUMIS INC ALMS · Call | $10.0m356.3k shares | Added |
| KODIAK SCIENCES INC KOD · Call | $8.5m217.7k shares | Added |
| CAPRICOR THERAPEUTICS INC CAPR · Call | $8.4m350.0k shares | Unchanged |
| ARROWHEAD PHARMACEUTICALS IN ARWR · Put | $8.2m100.0k shares | Added |
| PRAXIS PRECISION MEDICINES I PRAX · Call | $6.7m20.0k shares | New |
| KYMERA THERAPEUTICS INC KYMR · Put | $5.8m50.4k shares | Unchanged |
| TENAX THERAPEUTICS INC TENX · Call | $5.4m373.1k shares | Added |
| EYEPOINT PHARMACEUTICALS INC EYPT · Put | $5.3m370.4k shares | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT · Call | $5.3m370.4k shares | Unchanged |
| SELLAS LIFE SCIENCES GROUP I SLS · Put | $5.2m354.7k shares | New |
| SIONNA THERAPEUTICS INC SION · Put | $4.7m107.5k shares | New |
| CELLDEX THERAPEUTICS INC NEW CLDX · Put | $4.2m114.0k shares | Unchanged |
| VERA THERAPEUTICS INC VERA · Call | $3.1m71.7k shares | Unchanged |
| Q32 BIO INC QTTB · Put | $2.5m200.0k shares | New |
| OLEMA PHARMACEUTICALS INC OLMA · Call | $2.5m200.0k shares | Reduced |
| BRISTOL-MYERS SQUIBB CO BMY · Put | $2.4m42.5k shares | Reduced |
| UNIQURE NV QURE · Call | $2.3m49.8k shares | Reduced |
| DISC MEDICINE INC IRON · Put | $972.8k13.3k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |